BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $262,290 | -33.4% | 5,987 | 0.0% | 0.11% | -31.8% |
Q3 2022 | $394,000 | +30.5% | 5,987 | 0.0% | 0.16% | +35.3% |
Q2 2022 | $302,000 | -22.6% | 5,987 | -2.0% | 0.12% | -15.9% |
Q1 2022 | $390,000 | -42.1% | 6,112 | -2.9% | 0.14% | -40.0% |
Q4 2021 | $674,000 | +1.7% | 6,292 | -2.5% | 0.23% | -5.3% |
Q3 2021 | $663,000 | +6.6% | 6,452 | -8.7% | 0.24% | +5.7% |
Q2 2021 | $622,000 | -11.9% | 7,070 | -2.7% | 0.23% | -12.2% |
Q1 2021 | $706,000 | -23.4% | 7,265 | -11.7% | 0.26% | -25.1% |
Q4 2020 | $922,000 | +20.5% | 8,225 | -0.4% | 0.35% | +6.7% |
Q3 2020 | $765,000 | +17.3% | 8,255 | -1.2% | 0.33% | +7.2% |
Q2 2020 | $652,000 | +31.2% | 8,355 | -1.8% | 0.31% | +15.0% |
Q1 2020 | $497,000 | -15.2% | 8,505 | +16.2% | 0.27% | +1.9% |
Q4 2019 | $586,000 | +8.5% | 7,320 | -0.3% | 0.26% | -19.9% |
Q3 2019 | $540,000 | -22.1% | 7,345 | 0.0% | 0.33% | -19.5% |
Q2 2019 | $693,000 | +41.1% | 7,345 | +19.7% | 0.40% | +38.7% |
Q1 2019 | $491,000 | -31.5% | 6,135 | -53.9% | 0.29% | -46.3% |
Q4 2018 | $717,000 | – | 13,305 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |